Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging

[1]  S. Hussain,et al.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.

[2]  G. Delso,et al.  Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner , 2011, The Journal of Nuclear Medicine.

[3]  Ilja Bezrukov,et al.  MRI-Based Attenuation Correction for Whole-Body PET/MRI: Quantitative Evaluation of Segmentation- and Atlas-Based Methods , 2011, The Journal of Nuclear Medicine.

[4]  H. Zaidi,et al.  Design and performance evaluation of a whole-body Ingenuity TF PET–MRI system , 2011, Physics in medicine and biology.

[5]  J. Kang,et al.  Effects of MR contrast agents on PET quantitation in PET-MRI study , 2011 .

[6]  Thomas Beyer,et al.  Whole-body hybrid PET/MRI: ready for clinical use? , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  Osman Ratib,et al.  Whole body PET-MRI scanner: First experience in oncology , 2010 .

[8]  Heinz-Peter Schlemmer,et al.  PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications , 2010, Journal of Nuclear Medicine.

[9]  S. Basu,et al.  Combined 18F-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future? , 2010, Journal of Nuclear Medicine.

[10]  R. Günther,et al.  Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  Cyrill Burger,et al.  Integrating imaging modalities: what makes sense from a workflow perspective? , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  Nassir Navab,et al.  Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data , 2009, Journal of Nuclear Medicine.

[13]  H. Schlemmer,et al.  A look ahead: PET/MR versus PET/CT , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  B. Schölkopf,et al.  Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  Myeong-Jin Kim,et al.  MR cholangiography for evaluation of hilar branching anatomy in transplantation of the right hepatic lobe from a living donor. , 2008, AJR. American journal of roentgenology.

[16]  C. Hoeffel,et al.  Utilisation du jus d’ananas en tant qu’agent de contraste négatif en cholangiopancréatographie par résonance magnétique , 2007 .

[17]  J. Poupon,et al.  [Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography]. , 2007, Journal de radiologie.

[18]  S. Schoenberg,et al.  Effects of injection rate and dose on image quality in time-resolved magnetic resonance angiography (MRA) by using 1.0M contrast agents , 2007, European Radiology.

[19]  Marie-France Bellin,et al.  MR contrast agents, the old and the new. , 2006, European journal of radiology.

[20]  Tinsu Pan,et al.  Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. , 2006, AJR. American journal of roentgenology.

[21]  Roberta Matheoud,et al.  Performance characteristics obtained for a new 3-dimensional lutetium oxyorthosilicate-based whole-body PET/CT scanner with the National Electrical Manufacturers Association NU 2-2001 standard. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Philippe Robert,et al.  Optimization of a blood pool contrast agent injection protocol for MR angiography , 2005, Journal of magnetic resonance imaging : JMRI.

[23]  P. Vernon,et al.  Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  G. Maskell,et al.  Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography: a preliminary evaluation. , 2004, The British journal of radiology.

[25]  A. Huppertz,et al.  Gadobutrol, a highly concentrated MR imaging contrast agent: its physicochemical characteristics and the basis for its use in contrast-enhanced MR angiography and in perfusion imaging , 2004, European radiology.

[26]  J. Tropp,et al.  Image brightening in samples of high dielectric constant. , 2004, Journal of magnetic resonance.

[27]  Thomas Beyer,et al.  To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  Thomas Beyer,et al.  X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. , 2003, Seminars in nuclear medicine.

[29]  R. Wahl,et al.  Initial experience with oral contrast in PET/CT: phantom and clinical studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  Chuanyong Bai,et al.  A generalized model for the conversion from CT numbers to linear attenuation coefficients , 2002, 2002 IEEE Nuclear Science Symposium Conference Record.

[31]  Gerald Antoch,et al.  Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  W. Heindel,et al.  Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrol , 2002, European Radiology.

[33]  Mukta Dooley,et al.  Iomeprol: a review of its use as a contrast medium. , 2000, Drugs.

[34]  E. Rostrup,et al.  Measurement of the arterial concentration of Gd‐DTPA using MRI: A step toward quantitative perfusion imaging , 1996, Magnetic resonance in medicine.

[35]  K Wienhard,et al.  The ECAT EXACT HR: Performance of a New High Resolution Positron Scanner , 1994, Journal of computer assisted tomography.

[36]  R Weissleder,et al.  First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. , 1990, Radiology.

[37]  T. Budinger.  Time-of-flight positron emission tomography: status relative to conventional PET. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  R. Hingorani,et al.  Direct Fourier reconstruction in computer tomography , 1981 .